About this book
Over recent years, there has been a dramatic increase in knowledge of the biology of the lymphomas which has been accompanied by the emergence of new treatments that offer both improvements in efficacy and reduction in toxicity. Molecular profiling of tumor tissue and other new advances have led to a better understanding of the genetic basis of lymphoma, identification of new therapeutic targets, and potentially valuable prognostic information. Monoclonal antibody therapies, radioimmunoconjugates and other new agents such as proteosome inhibitors are providing important new treatment options for patients.
In this volume, an internationally recognized group of experts provides a comprehensive overview of the biology, pathology, standard treatments, and novel approaches in management of patients across the complex landscape of lymphoma subtypes. Researchers and practitioners alike will welcome this useful summary of the state of the art in this field.
Oncologists, hematologists, pathologists, radiologists and radiation oncologists, researchers, medical libraries, pharmaceutical companies
non-hodgkin's lymphoma, Hodgkin's disease, lymphoma, monoclonal antibodies, hematopathology, radioimmunotherapy, vaccine therapy
Table of contents
Pathology of Hodgkin's Disease.- Management of Early Stage Hodgkin's Disease.- Management of Advanced Stage Hodgkin's Disease.- Non-Classical Hodgkin's Disease.- Pathology of T Cell NHL.- Pathology of B Cell NHL.- Viruses and Lymphoma.- Imaging Modalities for Lymphoma.- Indolent B Cell NHL.- Diffuse Large B Cell NHL.- Mantle Cell Lymphoma.- High Grade NHL.- Cutaneous and T Cell Lymphomas.- Bone Marrow and Stem Cell Transplantation for Lymphoma.- Monoclonal Antibodies and Radioimmunotherapy for Lymphoma.- Vaccine Therapy for Lymphoma.- New Agents for Lymphoma.